Canada's health care faces reform

27 February 2006

With the appointment of the former Health Minister for the Canadian province of Ontario, Tony Clement, to the position of federal Minister for Health in the new Conser-vative government, critics of Canada's publicly-funded health care system sense an opportunity for change. Brett Skinner, Director of Health and Pharmaceutical Policy Research at the Vancouver, Canada-based Fraser Institute, has presented a shopping list of reforms from the free-market oriented think-tank. He warns that allowing Cana-dian Internet pharmacists to export drugs to the USA (Marketletters passim) runs the risk of causing shortages in Canada, given the size of the US market, a problem that will get worse if more US citizens buy Canadian.

Writing in the Canadian daily newspaper the National Post, Mr Skinner says: "the number of American consumers who would be legally eligible to buy cross-border drugs under these proposals is conservatively estimated to be almost 119 million, or nearly four times Canada's entire population of approximately 32 million."

Price control = profits for Internet pharmacists

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight